Deruizhiyao

$52.0M Series B

Announced: Jul 8, 2026
Sector: AI drug discovery
Investors: 2

Summary

Deruizhiyao raised US$52 million in a Series B round from unnamed renminbi and US dollar funds. The company plans to use the capital to improve its AI drug discovery platform and support phase III trials and commercialization of its oral GLP-1 drug candidate MDR-001.

Investors

unnamed renminbi funds, unnamed US dollar funds